HELP · Helus Pharma
AI read · Good for HELP
The AI's read
A higher target means Guggenheim sees more potential in Helus Pharma shares. The report adds no new trial, sales, or profit results, so this signal rests on one firm's view.
Guggenheim raised its target, signaling a more favorable view of Helus Pharma shares. The report gives no new company results, so the support comes only from the analyst's opinion.
A higher target means Guggenheim sees more potential in Helus Pharma shares. The report adds no new trial, sales, or profit results, so this signal rests on one firm's view.
Follow Helus Pharma (HELP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HELP